Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines
Open Access
- 28 May 2010
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 62 (6) , 791-799
Abstract
Objective: This study examines the determinants of patients' side effects from arthritis medication. Proposed predictors were patients' beliefs about medications, objective disease activity, treatment regimen, and psychiatric and rheumatoid arthritis symptoms.Methods: In a longitudinal design, 100 rheumatoid arthritis outpatients were investigated at baseline and again at 6 months after receiving both pharmacologic and psychosocial treatment.Results: Multivariate analyses showed no influence of disease status, type of treatment, or psychiatric or arthritis symptoms on side effects. Heightened concerns about arthritis medication at baseline predicted side effects at baseline (partial correlation r = 0.37, P < 0.001) and at 6 months (partial correlation r = 0.25, P < 0.001) after controlling for relevant disease‐ and treatment‐related variables. In a cross‐lagged panel analysis, prior experience with side effects from arthritis medication was ruled out as a cause of heightened concerns, indicating that negative beliefs genuinely contribute to side effects. A comparison of patients who did and did not start new medications showed no difference in side effects in patients with positive beliefs about medications, but led to significantly more side effects in patients with negative beliefs.Conclusion: Patients' beliefs about arthritis medications were stable and consistently associated with side effects. Patients with greater concerns about their arthritis medications are at higher risk for developing side effects, especially when starting new drugs. Identifying those patients is important to avoid premature drug discontinuation. Research into cause and preventability of negative attitudes to prescribed medicines is needed.Keywords
This publication has 45 references indexed in Scilit:
- Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant TrialsDrug Safety, 2009
- Incidence, severity and preventability of medication-related visits to the emergency department: a prospective studyCanadian Medical Association Journal, 2008
- Medication-Attributed Adverse Effects in Placebo GroupsArchives of internal medicine (1960), 2006
- The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medicationPsychology & Health, 1999
- Side effect profile and adherence to in the treatment of Multiple Sclerosis with interferon beta-laMultiple Sclerosis Journal, 1998
- GPOWER: A general power analysis programBehavior Research Methods, Instruments, & Computers, 1996
- Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activityArthritis & Rheumatism, 1995
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- A Test of Missing Completely at Random for Multivariate Data with Missing ValuesJournal of the American Statistical Association, 1988
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988